Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Share-based Compensation: 2017-2024

Historic Share-based Compensation for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $38.1 million.

  • Bicycle Therapeutics' Share-based Compensation fell 4.68% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 7.27%. This contributed to the annual value of $38.1 million for FY2024, which is 17.26% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Share-based Compensation of $38.1 million as of FY2024, which was up 17.26% from $32.5 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Share-based Compensation ranged from a high of $38.1 million in FY2024 and a low of $6.5 million during FY2020.
  • For the 3-year period, Bicycle Therapeutics' Share-based Compensation averaged around $32.4 million, with its median value being $32.5 million (2023).
  • Data for Bicycle Therapeutics' Share-based Compensation shows a peak YoY surged of 121.63% (in 2022) over the last 5 years.
  • Bicycle Therapeutics' Share-based Compensation (Yearly) stood at $6.5 million in 2020, then soared by 85.49% to $12.1 million in 2021, then skyrocketed by 121.63% to $26.8 million in 2022, then grew by 21.28% to $32.5 million in 2023, then rose by 17.26% to $38.1 million in 2024.